| 发明名称 |
Topoisomerase inhibitors |
| 摘要 |
The present invention relates to novel N12, N13-bridged sugar derivatives of indolylopyrrolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
|
| 申请公布号 |
US2002107237(A1) |
申请公布日期 |
2002.08.08 |
| 申请号 |
US20010965976 |
申请日期 |
2001.09.27 |
| 申请人 |
SAULNIER MARK G.;RUEDIGER EDWARD H.;BALASUBRAMANIAN NEELAKANTAN;MAHLER MIKAEL;BEAULIEU FRANCIS;BACHAND CAROL;FRENNESSON DAVID B. |
发明人 |
SAULNIER MARK G.;RUEDIGER EDWARD H.;BALASUBRAMANIAN NEELAKANTAN;MAHLER MIKAEL;BEAULIEU FRANCIS;BACHAND CAROL;FRENNESSON DAVID B. |
| 分类号 |
C07H9/04;A61K31/7056;A61P35/00;A61P43/00;C07H9/06;C07H19/23;(IPC1-7):A61K31/553;A61K31/551;C07D498/16 |
主分类号 |
C07H9/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
